Detalhe da pesquisa
1.
Chromothriptic cure of WHIM syndrome.
Cell
; 160(4): 686-699, 2015 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-25662009
2.
Standardized indolent systemic mastocytosis evaluations across a healthcare system: implications for screening accuracy.
Blood
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38635793
3.
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
Mol Ther
; 32(2): 503-526, 2024 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38155568
4.
Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia.
J Allergy Clin Immunol
; 153(3): 821-830.e6, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37951310
5.
False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay.
Acta Haematol
; 146(4): 316-321, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37285821
6.
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.
N Engl J Med
; 380(14): 1336-1346, 2019 04 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30943337
7.
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Blood
; 136(1): 93-105, 2020 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32202637
8.
A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis.
J Allergy Clin Immunol
; 147(3): 1004-1010.e2, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33220353
9.
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
Oncologist
; 26(4): 288-e541, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33554406
10.
Homozygous splice-variants in human ARV1 cause GPI-anchor synthesis deficiency.
Mol Genet Metab
; 130(1): 49-57, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32165008
11.
A rare case of well-differentiated systemic mastocytosis.
Blood
; 141(19): 2403, 2023 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37166923
12.
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.
Blood
; 132(5): 501-509, 2018 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29739754
13.
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.
Blood
; 131(21): 2357-2366, 2018 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-29483101
14.
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
J Immunol
; 201(7): 1967-1974, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30104242
15.
Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
J Allergy Clin Immunol
; 143(6): 2227-2237.e10, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30543818
16.
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Blood
; 129(11): 1469-1479, 2017 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-28049639
17.
A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.
J Allergy Clin Immunol
; 141(1): 180-188.e3, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28629749
18.
Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
Br J Haematol
; 183(5): 775-782, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30488427
19.
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
; 128(13): 1688-700, 2016 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27412889
20.
Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia.
Blood
; 127(8): 977-88, 2016 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-26675348